91138-06-6 Usage
Uses
Used in Pharmaceutical Industry:
5-(benzyloxy)pyrimidin-4(3H)-one is used as a pharmacological agent for its potential role as an inhibitor of protein kinase C (PKC). This makes it a candidate for the development of treatments targeting diseases associated with PKC dysregulation, such as cancer and diabetes.
Used in Medicinal Chemistry:
5-(benzyloxy)pyrimidin-4(3H)-one is utilized as a building block or a starting compound in the synthesis of new drugs due to its heterocyclic structure, which can be further modified to create a variety of medicinally relevant compounds.
Used in Drug Development:
As a pyrimidine derivative with potential biological activities, 5-(benzyloxy)pyrimidin-4(3H)-one is used in drug development to explore its efficacy and safety in treating specific conditions, with the aim of advancing it through preclinical and clinical trials.
Further research and clinical studies may be required to fully understand the biological activities and potential pharmaceutical uses of 5-(benzyloxy)pyrimidin-4(3H)-one, ensuring its safe and effective application in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 91138-06-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,3 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91138-06:
(7*9)+(6*1)+(5*1)+(4*3)+(3*8)+(2*0)+(1*6)=116
116 % 10 = 6
So 91138-06-6 is a valid CAS Registry Number.
91138-06-6Relevant academic research and scientific papers
STEROID SPARING AGENTS AND METHODS OF USING SAME
-
Page/Page column 537; 560, (2010/02/14)
This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.
